XNAS: DCTH
Delcath Systems Inc Live Stock Price Today, Share Analysis and Chart
about
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or ...
Read More
12.24
-0.05
(-0.41%)
468.0K
XNAS Volume
XNAS 24 Jun, 2026 5:30 PM (EDT)
Medium Financial Strength
Mid Valuation
Technically Moderately Bullish
Turnaround Potential
These stocks have average financials and valuation, but strong momentum indicating buying interest
View Similar
Embed DVM
Delcath Systems Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..